- Home
- JANX vs LTC Comparison
JANX vs LTC Comparison
Compare JANX & LTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- LTC
- Stock Information
- Founded
- JANX 2017
- LTC 1992
- Country
- JANX United States
- LTC United States
- Employees
- JANX N/A
- LTC N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- LTC Real Estate Investment Trusts
- Sector
- JANX Health Care
- LTC Real Estate
- Exchange
- JANX Nasdaq
- LTC Nasdaq
- Market Cap
- JANX 1.4B
- LTC 1.6B
- IPO Year
- JANX 2021
- LTC 1992
- Fundamental
- Price
- JANX $24.87
- LTC $35.51
- Analyst Decision
- JANX Strong Buy
- LTC Hold
- Analyst Count
- JANX 8
- LTC 5
- Target Price
- JANX $90.63
- LTC $38.60
- AVG Volume (30 Days)
- JANX 892.8K
- LTC 378.2K
- Earning Date
- JANX 08-07-2025
- LTC 08-04-2025
- Dividend Yield
- JANX N/A
- LTC 6.42%
- EPS Growth
- JANX N/A
- LTC N/A
- EPS
- JANX N/A
- LTC 1.81
- Revenue
- JANX $439,000.00
- LTC $213,197,000.00
- Revenue This Year
- JANX N/A
- LTC N/A
- Revenue Next Year
- JANX $1,470.83
- LTC $11.85
- P/E Ratio
- JANX N/A
- LTC $19.64
- Revenue Growth
- JANX N/A
- LTC 8.74
- 52 Week Low
- JANX $21.97
- LTC $31.70
- 52 Week High
- JANX $71.71
- LTC $39.89
- Technical
- Relative Strength Index (RSI)
- JANX 51.13
- LTC 54.56
- Support Level
- JANX $23.96
- LTC $35.34
- Resistance Level
- JANX $25.93
- LTC $36.14
- Average True Range (ATR)
- JANX 1.55
- LTC 0.64
- MACD
- JANX 0.06
- LTC 0.09
- Stochastic Oscillator
- JANX 61.91
- LTC 74.67
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About LTC LTC Properties Inc.
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in seniors housing and healthcare facilities through mortgage loans, property lease transactions, and other investments. Its real estate investments includes different types of properties such as Independent living communities, Assisted living communities, Memory care communities, Skilled nursing centers and other types of properties.